Business · 25/09/2009Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Withdrawal of 103 New Drug Applications and 35 Abbreviated New Drug Applications
Summary
The FDA is correcting a notice that incorrectly identified an Abbreviated New Drug Application (ANDA) for Amiodarone Hydrochloride Injection, 50 milligrams/milliliter, held by Hospira, Inc., in a February 11, 2009, Federal Register notice announcing the withdrawal of 103 new drug applications (NDAs) and 35 ANDAs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →